Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neerja Bhatla

Showing results (241-250 of 249) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 249 results.
Human Vaccines & Immunotherapeutics|December 11, 2023
Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccineNeerja Bhatla, Richard Muwonge, Sylla G Malvi, et al.
Journal of Global Oncology|August 8, 2018
National Cancer Grid of India Consensus Guidelines on the Management of Cervical CancerSupriya J Chopra, Ashwathy Mathew, Amita Maheshwari, et al.
Vaccine|November 29, 2022
Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccinationSmita Joshi, Devasena Anantharaman, Richard Muwonge, et al.
Papillomavirus Research (Amsterdam, Netherlands)|March 27, 2018
Are two doses of human papillomavirus vaccine sufficient for girls aged 15-18 years? Results from a cohort study in IndiaNeerja Bhatla, Bhagwan M Nene, Smita Joshi, et al.
Cancer Causes & Control : CCC|September 4, 2015
Report from a symposium on catalyzing primary and secondary prevention of cancer in IndiaSuneeta Krishnan, Preet K Dhillon, Afsan Bhadelia, et al.
Papillomavirus Research (Amsterdam, Netherlands)|February 4, 2019
Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years - updated evidence from Indian follow-up cohort studyPartha Basu, Richard Muwonge, Neerja Bhatla, et al.
The Lancet. Oncology|December 15, 2015
Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort studyRengaswamy Sankaranarayanan, Priya Ramesh Prabhu, Michael Pawlita, et al.
Plos One|March 6, 2023
SCOPE: Surveillance of COVID-19 in pregnancy- results of a multicentric ambispective case-control study on clinical presentation and maternal outcomes in India between April to November 2020Sunesh Kumar, Neerja Bhatla, K Aparna Sharma, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2013
Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulvaSilvia de Sanjosé, Laia Alemany, Jaume Ordi, et al.
Pageof 25

Showing results (241-250 of 249) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 249 results.
Human Vaccines & Immunotherapeutics|December 11, 2023
Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccineNeerja Bhatla, Richard Muwonge, Sylla G Malvi, et al.
Journal of Global Oncology|August 8, 2018
National Cancer Grid of India Consensus Guidelines on the Management of Cervical CancerSupriya J Chopra, Ashwathy Mathew, Amita Maheshwari, et al.
Vaccine|November 29, 2022
Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccinationSmita Joshi, Devasena Anantharaman, Richard Muwonge, et al.
Papillomavirus Research (Amsterdam, Netherlands)|March 27, 2018
Are two doses of human papillomavirus vaccine sufficient for girls aged 15-18 years? Results from a cohort study in IndiaNeerja Bhatla, Bhagwan M Nene, Smita Joshi, et al.
Cancer Causes & Control : CCC|September 4, 2015
Report from a symposium on catalyzing primary and secondary prevention of cancer in IndiaSuneeta Krishnan, Preet K Dhillon, Afsan Bhadelia, et al.
Papillomavirus Research (Amsterdam, Netherlands)|February 4, 2019
Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years - updated evidence from Indian follow-up cohort studyPartha Basu, Richard Muwonge, Neerja Bhatla, et al.
The Lancet. Oncology|December 15, 2015
Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort studyRengaswamy Sankaranarayanan, Priya Ramesh Prabhu, Michael Pawlita, et al.
Plos One|March 6, 2023
SCOPE: Surveillance of COVID-19 in pregnancy- results of a multicentric ambispective case-control study on clinical presentation and maternal outcomes in India between April to November 2020Sunesh Kumar, Neerja Bhatla, K Aparna Sharma, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2013
Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulvaSilvia de Sanjosé, Laia Alemany, Jaume Ordi, et al.
Pageof 25